Federal Register / Vol. 86, No. 34 / Tuesday, February 23, 2021 / Notices 10989 

747. Catherine Dicus, Tulsa, Oklahoma, 

Court of Federal Claims No: 21–0780V 

748. Sara MacPhee, Washington, District of 

Columbia, Court of Federal Claims No: 

21–0781V 

749. Lynn Duclos, Washington, District of 

Columbia, Court of Federal Claims No: 

21–0782V 

750. Sean Jiggins, Washington, District of 

Columbia, Court of Federal Claims No: 

21–0783V 

751. Sarah Holbrook-Lipscomb on behalf of 

M.L., Phoenix, Arizona, Court of Federal 

Claims No: 21–0784V 

752. Lebrian Spaugh, Washington, District of 

Columbia, Court of Federal Claims No: 

21–0785V 

753. Kathryn Alexander, Englewood, New 

Jersey, Court of Federal Claims No: 21– 

0786V 

754. Alane Babington, Wellesley Hills, 

Massachusetts, Court of Federal Claims 

No: 21–0789V 

755. Naomi Mimnaugh, Wellesley Hills, 

Massachusetts, Court of Federal Claims 

No: 21–0790V 

756. Robert J. Owens, Sr., Wellesley Hills, 

California, Court of Federal Claims No: 

21–0791V 

757. Dayna Higgins, Wellesley Hills, 

Massachusetts, Court of Federal Claims 

No: 21–0792V 

758. Mary Saville, Washington, District of 

Columbia, Court of Federal Claims No: 

21–0794V 

759. Wanda Lange, Houston, Texas, Court of 

Federal Claims No: 21–0797V 

760. Rocelyn Nepomuceno, Boston, 

Massachusetts, Court of Federal Claims 

No: 21–0798V 

761. Hanna Ozarski, New York, New York, 

Court of Federal Claims No: 21–0800V 

762. Corrine O’Sullivan-Bradley, Rochester, 

New York, Court of Federal Claims No: 

21–0802V 

763. Vincent R. Bedogne, Farmington Hills, 

Michigan, Court of Federal Claims No: 

21–0803V 

764. Haley Faro, Rochester, New York, Court 

of Federal Claims No: 21–0805V 

765. James Malkin, Boston, Massachusetts, 

Court of Federal Claims No: 21–0806V 

766. Malikia Craddle, Washington, District of 

Columbia, Court of Federal Claims No: 

21–0808V 

767. Martha T. Cunningham, Tucson, 

Arizona, Court of Federal Claims No: 21– 

0809V 

768. Nabila Gebran, White Plains, New York, 

Court of Federal Claims No: 21–0810V 

769. Bryce Maddox, Englewood, New Jersey, 

Court of Federal Claims No: 21–0811V 

770. Edna Groen, Covington, Kentucky, Court 

of Federal Claims No: 21–0812V 

771. Jeanine John, Seattle, Washington, Court 

of Federal Claims No: 21–0813V 

772. Pete Heffron, Solana Beach, California, 

Court of Federal Claims No: 21–0814V 

773. Fatima Collins, Fort Worth, Texas, Court 

of Federal Claims No: 21–0815V 

774. Linda Garcia, San Antonio, Texas, Court 

of Federal Claims No: 21–0816V 

775. Holly Jenkins, Washington, District of 

Columbia, Court of Federal Claims No: 

21–0819V 

776. Danielle Awe, Boston, Massachusetts, 

Court of Federal Claims No: 21–0821V 

777. Marlene Koenig-Wiltse, Washington, 

District of Columbia, Court of Federal 

Claims No: 21–0822V 

778. Edward Tyson, Washington, District of 

Columbia, Court of Federal Claims No: 

21–0823V 

779. Marie Galeno, Dresher, Pennsylvania, 

Court of Federal Claims No: 21–0824V 

780. Ramon Pinon, Seattle, Washington, 

Court of Federal Claims No: 21–0825V 

781. Kacy Barker, Boston, Massachusetts, 

Court of Federal Claims No: 21–0826V 

782. Kim Hill, Russellville, Alabama, Court 

of Federal Claims No: 21–0848V 

[FR Doc. 2021–03610 Filed 2–22–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group; Microbiology and Infectious Diseases 

Research Committee Microbiology and 

Infectious Diseases Research Committee 

(MID). 

Date: May 26–27, 2021. 

Time: 10:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G51, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Amir E. Zeituni, Ph.D., 

Scientific Review Program, Division of 

Extramural Activities, National Institute of 

Allergy and Infectious Diseases, National 

Institutes of Health 5601 Fishers Lane, Room 

3G51 Rockville, MD 20852, 301–496–2550, 

amir.zeituni@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 17, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–03612 Filed 2–22–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Mucosal Immunology 

Studies Team (MIST) (U01 Clinical Trial Not 

Allowed). 

Date: March 22–23, 2021. 

Time: 10:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G42, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Sandip Bhattacharyya, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G42, 

Rockville, MD 20852, 240–292–0189, 

sandip.bhattacharyya@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 17, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–03613 Filed 2–22–21; 8:45 am] 

BILLING CODE 4140–01–P